Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016 (2016), Article ID 8390210, 7 pages
http://dx.doi.org/10.1155/2016/8390210
Research Article

Glycated Hemoglobin Levels in Patients with Decompensated Cirrhosis

1Division of Gastroenterology and Hepatology, University of Tennessee Health Sciences Center, Memphis, TN, USA
2Methodist Transplant Institute, Division of Surgery, University of Tennessee Health Sciences Center, Memphis, TN, USA

Received 20 April 2016; Revised 27 July 2016; Accepted 18 September 2016

Academic Editor: Dario Iafusco

Copyright © 2016 Jeffrey Nadelson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. R. Wanless and J. S. Lentz, “Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors,” Hepatology, vol. 12, no. 5, pp. 1106–1110, 1990. View at Publisher · View at Google Scholar · View at Scopus
  2. Z. M. Younossi, T. Gramlich, C. A. Matteoni, N. Boparai, and A. J. McCullough, “Nonalcoholic fatty liver disease in patients with type 2 diabetes,” Clinical Gastroenterology and Hepatology, vol. 2, no. 3, pp. 262–265, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. L. A. Adams, S. Sanderson, K. D. Lindor, and P. Angulo, “The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies,” Journal of Hepatology, vol. 42, no. 1, pp. 132–138, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. B. R. Yehia, A. J. Schranz, C. A. Umscheid, and V. Lo Re III, “The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis,” PLoS ONE, vol. 9, no. 7, Article ID e101554, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. J. D. Browning, L. S. Szczepaniak, R. Dobbins et al., “Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity,” Hepatology, vol. 40, no. 6, pp. 1387–1395, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. M. C. Blendea, M. J. Thompson, and S. Malkani, “Diabetes and chronic liver disease: etiology and pitfalls in monitoring,” Clinical Diabetes, vol. 28, no. 4, pp. 139–144, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. S. Petrides and R. A. De Fronzo, “Failure of glucagon to stimulate hepatic glycogenolysis in well-nourished patients with mild cirrhosis,” Metabolism, vol. 43, no. 1, pp. 85–89, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. D. García-Compean, J. O. Jaquez-Quintana, and H. Maldonado-Garza, “Hepatogenous diabetes. Current views of an ancient problem,” Annals of Hepatology, vol. 8, no. 1, pp. 13–20, 2009. View at Google Scholar · View at Scopus
  9. E. E. Morse, “Mechanisms of hemolysis in liver disease,” Annals of Clinical and Laboratory Science, vol. 20, no. 3, pp. 169–174, 1990. View at Google Scholar · View at Scopus
  10. W. J. Schnedl, T. Lahousen, R. Krause, S. J. Wallner, C. Piswanger-Soelkner, and R. W. Lipp, “Evaluation of conditions associated with glycated hemoglobin values below the reference range,” Clinical Laboratory, vol. 53, no. 3-4, pp. 179–181, 2007. View at Google Scholar · View at Scopus
  11. T. Lahousen, K. Hegenbarth, R. Ille et al., “Determination of glycated hemoglobin in patients with advanced liver disease,” World Journal of Gastroenterology, vol. 10, no. 15, pp. 2284–2286, 2004. View at Google Scholar · View at Scopus
  12. American Diabetes Association, “Standards of medical care in diabetes—2010,” Diabetes Care, vol. 33, supplement 1, pp. S11–S61, 2010. View at Google Scholar
  13. S. Maruyama, C. Hirayama, S. Yamamoto et al., “Red blood cell status in alcoholic and non-alcoholic liver disease,” Journal of Laboratory and Clinical Medicine, vol. 138, no. 5, pp. 332–337, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Cacciatore, G. Cozzolino, M. G. Giardina et al., “Abnormalities of glucose metabolism induced by liver cirrhosis and glycosylated hemoglobin levels in chronic liver disease,” Diabetes Research, vol. 7, no. 4, pp. 185–188, 1988. View at Google Scholar · View at Scopus
  15. J. C. Garcia-Pagan, A. De Gottardi, and J. Bosch, “Review article: the modern management of portal hypertension—primary and secondary prophylaxis of variceal bleeding in cirrhotic patients,” Alimentary Pharmacology and Therapeutics, vol. 28, no. 2, pp. 178–186, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. J. G. Abraldes and J. Bosch, “The treatment of acute variceal bleeding,” Journal of Clinical Gastroenterology, vol. 41, supplement 3, pp. S312–S317, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Kravetz, “Prevention of recurrent esophageal variceal hemorrhage: review and current recommendations,” Journal of Clinical Gastroenterology, vol. 41, no. 3, pp. S318–S322, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Gonzalez-Casas, L. Garcia-Buey, E. A. Jones, J. P. Gisbert, and R. Moreno-Otero, “Systematic review: hepatitis-associated aplastic anaemia—a syndrome associated with abnormal immunological function,” Alimentary Pharmacology and Therapeutics, vol. 30, no. 5, pp. 436–443, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. N. S. Young, R. T. Calado, and P. Scheinberg, “Current concepts in the pathophysiology and treatment of aplastic anemia,” Blood, vol. 108, no. 8, pp. 2509–2519, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J. K. Davies and E. C. Guinan, “An update on the management of severe idiopathic aplastic anaemia in children,” British Journal of Haematology, vol. 136, no. 4, pp. 549–564, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. N. S. Young, P. Scheinberg, and R. T. Calado, “Aplastic anemia,” Current Opinion in Hematology, vol. 15, no. 3, pp. 162–168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Cariani, A. M. Pelizzari, A. Rodella et al., “Immune-mediated hepatitis-associated aplastic anemia caused by the emergence of a mutant hepatitis B virus undetectable by standard assays,” Journal of Hepatology, vol. 46, no. 4, pp. 743–747, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. J. P. Ong and Z. M. Younossi, “Managing the hematologic side effects of antiviral therapy for chronic hepatitis C: anemia, neutropenia, and thrombocytopenia,” Cleveland Clinic Journal of Medicine, vol. 71, supplement 3, pp. S17–S21, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Reau, S. J. Hadziyannis, D. Messinger, M. W. Fried, and D. M. Jensen, “Early predictors of anemia in patients with hepatitis C genotype 1 treated with peginterferon α-2a (40KD) plus ribavirin,” American Journal of Gastroenterology, vol. 103, no. 8, pp. 1981–1988, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Moreno Otero and J. R. Cortés, “Nutrition and chronic alcohol abuse,” Nutricion Hospitalaria, vol. 23, supplement 2, pp. 3–7, 2008. View at Google Scholar · View at Scopus
  26. G. N. Ioannou, J. A. Dominitz, N. S. Weiss, P. J. Heagerty, and K. V. Kowdley, “The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia,” Gastroenterology, vol. 126, no. 5, pp. 1293–1301, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Lindenbaum and M. J. Roman, “Nutritional anemia in alcoholism,” The American Journal of Clinical Nutrition, vol. 33, no. 12, pp. 2727–2735, 1980. View at Google Scholar · View at Scopus
  28. G. Laffi, F. Marra, R. Tarquini, and R. Abbate, “Coagulation defects in cirrhosis—old dogmas not yet ready for burial,” Journal of Thrombosis and Haemostasis, vol. 4, no. 9, pp. 2068–2069, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Bry, P. C. Chen, and D. B. Sacks, “Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin,” Clinical Chemistry, vol. 47, no. 2, pp. 153–163, 2001. View at Google Scholar · View at Scopus
  30. M. I. Harris, K. M. Flegal, C. C. Cowie et al., “Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988–1994,” Diabetes Care, vol. 21, no. 4, pp. 518–524, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. M. M. Hassan, L.-Y. Hwang, C. J. Hatten et al., “Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus,” Hepatology, vol. 36, no. 5, pp. 1206–1213, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. J.-M. Yuan, S. Govindarajan, K. Arakawa, and M. C. Yu, “Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S.,” Cancer, vol. 101, no. 5, pp. 1009–1017, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. J. A. Davila, R. O. Morgan, Y. Shaib, K. A. McGlynn, and H. B. El-Serag, “Diabetes increases the risk of hepatocellular carcinoma in the United States: A Population Based Case Control Study,” Gut, vol. 54, no. 4, pp. 533–539, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Ohki, R. Tateishi, T. Sato et al., “Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients,” Clinical Gastroenterology and Hepatology, vol. 6, no. 4, pp. 459–464, 2008. View at Publisher · View at Google Scholar
  35. Y. Torisu, K. Ikeda, M. Kobayashi et al., “Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: A Preliminary Report,” Hepatology Research, vol. 37, no. 7, pp. 517–523, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. B. J. Veldt, W. Chen, E. J. Heathcote et al., “Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus,” Hepatology, vol. 47, no. 6, pp. 1856–1862, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. H. B. El-Serag, H. Hampel, and F. Javadi, “The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence,” Clinical Gastroenterology and Hepatology, vol. 4, no. 3, pp. 369–380, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. S. A. Harrison, “Liver disease in patients with diabetes mellitus,” Journal of Clinical Gastroenterology, vol. 40, no. 1, pp. 68–76, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. D. S. H. Bell and E. Allbright, “The multifaceted associations of hepatobiliary disease and diabetes,” Endocrine Practice, vol. 13, no. 3, pp. 300–312, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Komura, E. Mizukoshi, Y. Kita et al., “Impact of diabetes on recurrence of hepatocellular carcinoma after surgical treatment in patients with viral hepatitis,” American Journal of Gastroenterology, vol. 102, no. 9, pp. 1939–1946, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Ikeda, M. Shimada, H. Hasegawa et al., “Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection,” Hepatology, vol. 27, no. 6, pp. 1567–1571, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Saydah, M. Tao, G. Imperatore, and E. Gregg, “GHb level and subsequent mortality among adults in the U.S.,” Diabetes Care, vol. 32, no. 8, pp. 1440–1446, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. A. L. Christman, M. Lazo, J. M. Clark, and E. Selvin, “Low glycated hemoglobin and liver disease in the U.S. population,” Diabetes Care, vol. 34, no. 12, pp. 2548–2550, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Ma, C. Xu, L. Xu, C. Yu, M. Miao, and Y. Li, “Independent association of HbA1c and nonalcoholic fatty liver disease in an elderly Chinese population,” BMC Gastroenterology, vol. 13, no. 1, article 3, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. X. Yang, Y. Wang, A. O. Y. Luk et al., “Enhancers and attenuators of risk associations of chronic hepatitis B virus infection with hepatocellular carcinoma in type 2 diabetes,” Endocrine-Related Cancer, vol. 20, no. 2, pp. 161–171, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. V. Donadon, M. Balbi, F. Valent, and A. Avogaro, “Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma,” World Journal of Gastroenterology, vol. 16, no. 24, pp. 3025–3032, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. X. Yang, G. T. C. Ko, W. Y. So et al., “Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry,” Diabetes, vol. 59, no. 5, pp. 1254–1260, 2010. View at Google Scholar
  48. S.-W. Lai, P.-C. Chen, K.-F. Liao, C.-H. Muo, C.-C. Lin, and F.-C. Sung, “Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study,” The American Journal of Gastroenterology, vol. 107, no. 1, pp. 46–52, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. C.-I. Li, H.-J. Chen, H.-C. Lai et al., “Hyperglycemia and chronic liver diseases on risk of hepatocellular carcinoma in Chinese patients with type 2 diabetes—National cohort of Taiwan Diabetes Study,” International Journal of Cancer, vol. 136, no. 11, pp. 2668–2679, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Parekh and F. A. Anania, “Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease,” Gastroenterology, vol. 132, no. 6, pp. 2191–2207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. G. C. Farrell and C. Z. Larter, “Nonalcoholic fatty liver disease: from steatosis to cirrhosis,” Hepatology, vol. 43, no. 2, supplement 1, pp. S99–S112, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. X. Yang, W.-Y. So, R. C. W. Ma, A. P. S. Kong, G. Xu, and J. C. N. Chan, “Diabetes and cancer: the mechanistic implications of epidemiological analyses from the Hong Kong Diabetes Registry,” Diabetes/Metabolism Research and Reviews, vol. 28, no. 5, pp. 379–387, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. G. A. Michelotti, M. V. Machado, and A. M. Diehl, “NAFLD, NASH and liver cancer,” Nature Reviews Gastroenterology and Hepatology, vol. 10, no. 11, pp. 656–665, 2013. View at Publisher · View at Google Scholar · View at Scopus